Optimization of Biotransformation Processes of <i>camarosporium Laburnicola</I> To Improve Production Yields of Potent Telomerase Activators
| dc.contributor.author | Kuecueksolak, Melis | |
| dc.contributor.author | Coban, Hasan Bugra | |
| dc.contributor.author | Bedir, Erdal | |
| dc.date.accessioned | 2024-09-24T15:48:33Z | |
| dc.date.available | 2024-09-24T15:48:33Z | |
| dc.date.issued | 2024 | |
| dc.description | KUCUKSOLAK, MELIS/0000-0003-1619-4850 | en_US |
| dc.description.abstract | Background Telomerase activators are promising agents for the healthy aging process and the treatment/prevention of short telomere-related and age-related diseases. The discovery of new telomerase activators and later optimizing their activities through chemical and biological transformations are crucial for the pharmaceutical sector. In our previous studies, several potent telomerase activators were discovered via fungal biotransformation, which in turn necessitated optimization of their production. It is practical to improve the production processes by implementing the design of experiment (DoE) strategy, leading to increased yield and productivity. In this study, we focused on optimizing biotransformation conditions utilizing Camarosporium laburnicola, a recently discovered filamentous fungus, to afford the target telomerase activators (E-CG-01, E-AG-01, and E-AG-02). Results DoE approaches were used to optimize the microbial biotransformation processes of C. laburnicola. Nine parameters were screened by Plackett-Burman Design, and three significant parameters (biotransformation time, temperature, shaking speed) were optimized using Central Composite Design. After conducting validation experiments, we were able to further enhance the production yield of target metabolites through scale-up studies in shake flasks (55.3-fold for E-AG-01, 13-fold for E-AG-02, and 1.96-fold for E-CG-01). Conclusion Following a process optimization study using C. laburnicola, a significant increase was achieved in the production yields. Thus, the present study demonstrates a promising methodology to increase the production yield of potent telomerase activators. Furthermore, C. laburnicola is identified as a potential biocatalyst for further industrial utilization. | en_US |
| dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [119Z870]; Izmir Institute of Technology Research Fund [2017Idot;YTE63] | en_US |
| dc.description.sponsorship | This project was supported by The Scientific and Technological Research Council of Turkey (TUBITAK, Project No.119Z870) and the Izmir Institute of Technology Research Fund (2017 & Idot;YTE63). We are very grateful to Bionorm Natural Products for donating cycloastragenol and astragenol. We thank Dr. Petek BALLAR KIRMIZIBAYRAK and Dr. Sinem YILMAZ for providing the telomerase activation data of E-AG-01, E-AG-02, and E-CG-01. We are very grateful to the Biotechnology and Bioengineering Application Research Centre (BIYOMER, Izmir Institute of Technology) for equipment support. | en_US |
| dc.identifier.doi | 10.1186/s12934-024-02468-0 | |
| dc.identifier.issn | 1475-2859 | |
| dc.identifier.scopus | 2-s2.0-85198119511 | |
| dc.identifier.uri | https://doi.org/10.1186/s12934-024-02468-0 | |
| dc.identifier.uri | https://hdl.handle.net/11147/14702 | |
| dc.language.iso | en | en_US |
| dc.publisher | Bmc | en_US |
| dc.relation.ispartof | Microbial Cell Factories | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Whole-cell biotransformation | en_US |
| dc.subject | Endophytic fungi | en_US |
| dc.subject | Process optimization | en_US |
| dc.subject | Anti-aging | en_US |
| dc.subject | Telomerase activator | en_US |
| dc.title | Optimization of Biotransformation Processes of <i>camarosporium Laburnicola</I> To Improve Production Yields of Potent Telomerase Activators | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | KUCUKSOLAK, MELIS/0000-0003-1619-4850 | |
| gdc.author.id | KUCUKSOLAK, MELIS / 0000-0003-1619-4850 | en_US |
| gdc.author.scopusid | 57205744287 | |
| gdc.author.scopusid | 57203104587 | |
| gdc.author.scopusid | 7003998497 | |
| gdc.author.wosid | Coban, Hasan/AAG-8131-2019 | |
| gdc.author.wosid | Küçüksolak, Melis/KXR-7620-2024 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Izmir Institute of Technology | en_US |
| gdc.description.departmenttemp | [Kuecueksolak, Melis; Bedir, Erdal] Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35430 Urla, Izmir, Turkiye; [Coban, Hasan Bugra] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, TR-35340 Balcova, Turkiye | en_US |
| gdc.description.issue | 1 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.volume | 23 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4400511232 | |
| gdc.identifier.pmid | 38987741 | |
| gdc.identifier.wos | WOS:001266039100001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 2.0 | |
| gdc.oaire.influence | 2.665184E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Endophytic fungi | |
| gdc.oaire.keywords | Research | |
| gdc.oaire.keywords | Enzyme Activators | |
| gdc.oaire.keywords | Anti-aging | |
| gdc.oaire.keywords | Microbiology | |
| gdc.oaire.keywords | QR1-502 | |
| gdc.oaire.keywords | Telomerase activator | |
| gdc.oaire.keywords | Whole-cell biotransformation | |
| gdc.oaire.keywords | Telomerase | |
| gdc.oaire.keywords | Biotransformation | |
| gdc.oaire.keywords | Process optimization | |
| gdc.oaire.popularity | 3.917399E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.96049445 | |
| gdc.openalex.normalizedpercentile | 0.66 | |
| gdc.openalex.toppercent | TOP 1% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 7 | |
| gdc.plumx.scopuscites | 1 | |
| gdc.scopus.citedcount | 1 | |
| gdc.wos.citedcount | 1 | |
| relation.isAuthorOfPublication.latestForDiscovery | 461a570d-2493-4349-b634-a876ced8cd22 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4015-8abe-a4dfe192da5e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- s12934-024-02468-0.pdf
- Size:
- 3.39 MB
- Format:
- Adobe Portable Document Format
- Description:
- article
